Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

March 31, 2010

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

Belotecan

3.0 mg/m2, Day 1, 8, 15 every 4 weeks

Sponsors
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

Seoul National University Hospital

OTHER

collaborator

Ulsan University Hospital

OTHER

lead

Chong Kun Dang Pharmaceutical

INDUSTRY